Table 2.
HLA haplotypes in the general population conferring significant risk for islet autoimmunity and type 1 diabetes.
| HLA-DQ | References |
|---|---|
| (a) Type 1 diabetes | |
|
| |
| Europeans | |
| A1*03:01-B1*03:02 | [54, 55] |
| A1*05:01-B1*02:01 | [56] |
| French native | |
| DRB1*04:05-DQA1*03:03-B1*03:02 | [57] |
| Mediterranean | |
| DRB1*04:05-DQ A1*03-B1*02 | |
| Black populations | |
| DRB1*07-DQ A1*03-B1*02 | |
| Japanese (haplotypes) | |
| DRB1*04:05-DQA1*03:01/02?-DQB1*04:01 | [35–37] |
| DRB1*09:01-DQA1*03:02-DQB1*03:03 | [35–37] |
| DRB1*08:02-DQA1*03:01-DQB1*03:02 | [36, 37] |
| DRB1*04:05-DQA1*03:01-DQB1*03:02 | [37] |
| DRB1*03:01-DQA1*05:01-DQB1*02:01 | [37] |
| DRB1*11:01-DQB1*03:01 | [36] |
| DRB1*11:01-DQB1*03:02 | [36] |
| DRB1*13:02-DQB1*06:04 | [36] |
| Koreans (haplotypes) | |
| DRB1*03:01-DQB1*02:01 | [58] |
| DRB1*04:01-DQB1*03:02 | [58] |
| DRB1*04:05-DQB1*03:02 | [58] |
| DRB1*04:07-DQB1*03:02 | [58] |
| DRB1*04:05-DQB1*04:01 | [35] |
| DRB1*09:01-DQB1*03:03 | [35, 58] |
| Chinese (haplotypes) | |
| DRB1*09:01-DQA1*03:01/02-B1*03:03 | [38] |
| DQA1*03-DQB1*03:03 | [39] |
| DQA1*03-DQB1*04:01 | [39] |
| DQA1*05-DQB1*02:01 | [39] |
| Indians (haplotypes) | |
| DRB1*03:01-DQA1*05:01-B1*02:01 | [59] |
| DRB1*04:01/02/04/05-DQA1*03:01/02-B1*02:01 | [38] |
| Sub-Saharan Africa (haplotypes) | |
| DRB1*03:01-DQA*05:01 | [60] |
| DRB1*04-DQA*03 | [60] |
| DRB1*04-DQB*03:02 | [60] |
| DRB1*03:01-DQB*02:01 | [60] |
| DQA*05:01-DQB*02:01 | [60] |
| DQA*03-DQB*03:02 | [60] |
| Latin America (haplotypes) | |
| DRB1*04:05-DQB1*03:02 | [61] |
| DRB1*03:01-DQB1*05:01 | [61] |
| DRB1*04:01-DQB1*03:02 | [61] |
| DRB1*04-DQA1*03:01-DQB1*03:02 | [61] |
|
| |
| (b) Insulin autoimmune syndrome (haplotypes) | |
|
| |
| DRB1*04:06-DQA1*03:01-B1*03:02 | [46, 47] |